1. Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in China
   Huiqin Liu et al, 2022, Health Economics Review CrossRef
2. Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases
   Dobrina Tsvetkova et al, 2022, Molecules CrossRef
3. Dashing Decades of Defeat: Long Anticipated Advances in the First-line Treatment of Extensive-Stage Small Cell Lung Cancer
   Samantha A. Armstrong et al, 2020, Current Oncology Reports CrossRef